How Helus’ new CEO plans to scale its psychedelic drug pipeline

How Helus’ new CEO plans to scale its psychedelic drug pipeline is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Kelly Bilodeau · 2026-08-18

Can Michael Halstead replicate the controlled growth he pulled off at Intra-Cellular Therapies in mental health’s psychedelic era?

Source: PharmaVoice